LOX and breast cancer: LOX inhibition (through BAPN) not only reduced collagen crosslinking and fibronectin assembly but also increased drug penetration and re-sensitized tumors to doxorubicin treatment in breast cancer [346], and enhanced sensitivity to radiotherapy in prostate cancer [347].